User profiles for "author:Catherine A Shaw"
Catherine A ShawSenior Lecturer, University of Edinburgh Verified email at ed.ac.uk Cited by 7898 |
From particles to patients: oxidative stress and the cardiovascular effects of air pollution
MR Miller, CA Shaw, JP Langrish - Future cardiology, 2012 - Future Medicine
Air pollution, especially airborne particulate matter (PM), is associated with an increase in
both morbidity and mortality from cardiovascular disease, although the underlying …
both morbidity and mortality from cardiovascular disease, although the underlying …
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C …
Objective To develop and validate a pragmatic risk score to predict mortality in patients
admitted to hospital with coronavirus disease 2019 (covid-19). Design Prospective …
admitted to hospital with coronavirus disease 2019 (covid-19). Design Prospective …
Nanoparticles and the cardiovascular system: a critical review
K Donaldson, R Duffin, JP Langrish, MR Miller… - …, 2013 - Future Medicine
Nanoparticles (NPs) are tiny particles with a diameter of less than 100 nm. Traffic exhaust is
a major source of combustion-derived NPs (CDNPs), which represent a significant …
a major source of combustion-derived NPs (CDNPs), which represent a significant …
[HTML][HTML] Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP …
Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
[HTML][HTML] Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study
RK Gupta, EM Harrison, A Ho, AB Docherty… - The Lancet …, 2021 - thelancet.com
Background Prognostic models to predict the risk of clinical deterioration in acute COVID-19
cases are urgently required to inform clinical management decisions. Methods We …
cases are urgently required to inform clinical management decisions. Methods We …
[HTML][HTML] Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective …
Background COVID-19 is a multisystem disease and patients who survive might have in-
hospital complications. These complications are likely to have important short-term and long …
hospital complications. These complications are likely to have important short-term and long …
[HTML][HTML] Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort …
A Bhangu, AO Ademuyiwa, ML Aguilera… - The Lancet Infectious …, 2018 - thelancet.com
Background Surgical site infection (SSI) is one of the most common infections associated
with health care, but its importance as a global health priority is not fully understood. We …
with health care, but its importance as a global health priority is not fully understood. We …
[HTML][HTML] Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort …
Background Studies of patients admitted to hospital with COVID-19 have found varying
mortality outcomes associated with underlying respiratory conditions and inhaled …
mortality outcomes associated with underlying respiratory conditions and inhaled …
[HTML][HTML] SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
F Liew, S Talwar, A Cross, BJ Willett, S Scott… - …, 2023 - thelancet.com
Background Most studies of immunity to SARS-CoV-2 focus on circulating antibody, giving
limited insights into mucosal defences that prevent viral replication and onward …
limited insights into mucosal defences that prevent viral replication and onward …
[HTML][HTML] Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective …
Background Early in the pandemic it was suggested that pre-existing use of non-steroidal
anti-inflammatory drugs (NSAIDs) could lead to increased disease severity in patients with …
anti-inflammatory drugs (NSAIDs) could lead to increased disease severity in patients with …